Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
 
Contents: Volume 47, Supplement 5, October 2008   [Index by Author] 

Down Article
Down Molecular Targets for Antifibrotic Therapy
Down Vascular Disease and Endothelin
Down Trial and Outcome Measures
Down Interstitial Lung Disease - Beyond Cyclophosphamide

 
Update in systemic sclerosis

Supported by an unrestricted educational grant from Encysive

Guest Editors: O. Distler, M. Matucci-Cerinic, U. Müller-Ladner, J. R. Seibold

[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Article Back

O. Distler, M. Matucci-Cerinic, U. Müller-Ladner, and J. R. Seibold
A path to the future in scleroderma
Rheumatology 2008 47: v1; doi:10.1093/rheumatology/ken351 [Extract] [Full Text] [PDF] [Request Permissions]  

Molecular Targets for Antifibrotic Therapy Back

M. Trojanowska
Role of PDGF in fibrotic diseases and systemic sclerosis
Rheumatology 2008 47: v2-v4; doi:10.1093/rheumatology/ken265 [Abstract] [Full Text] [PDF] [Request Permissions]  

R. Sgonc and G. Wick
Pro- and anti-fibrotic effects of TGF-β in scleroderma
Rheumatology 2008 47: v5-v7; doi:10.1093/rheumatology/ken275 [Abstract] [Full Text] [PDF] [Request Permissions]  

D. Abraham
Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Rheumatology 2008 47: v8-v9; doi:10.1093/rheumatology/ken278 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. H. W. Distler and O. Distler
Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis
Rheumatology 2008 47: v10-v11; doi:10.1093/rheumatology/ken276 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. H. W. Distler and O. Distler
Criteria to select molecular targets for anti-fibrotic therapy
Rheumatology 2008 47: v12-v13; doi:10.1093/rheumatology/ken277 [Abstract] [Full Text] [PDF] [Request Permissions]  

Vascular Disease and Endothelin Back

B. Kahaleh
The microvascular endothelium in scleroderma
Rheumatology 2008 47: v14-v15; doi:10.1093/rheumatology/ken279 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. J. F. Belch, S. McSwiggan, and C. Lau
Macrovascular disease in systemic sclerosis: the tip of an iceberg?
Rheumatology 2008 47: v16-v17; doi:10.1093/rheumatology/ken280 [Abstract] [Full Text] [PDF] [Request Permissions]  

S. Guiducci, O. Distler, J. H. W. Distler, and M. Matucci-Cerinic
Mechanisms of vascular damage in SSc—implications for vascular treatment strategies
Rheumatology 2008 47: v18-v20; doi:10.1093/rheumatology/ken267 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. K. Hummers
Biomarkers of vascular disease in scleroderma
Rheumatology 2008 47: v21-v22; doi:10.1093/rheumatology/ken281 [Abstract] [Full Text] [PDF] [Request Permissions]  

D. Abraham and M. Dashwood
Endothelin—role in vascular disease
Rheumatology 2008 47: v23-v24; doi:10.1093/rheumatology/ken282 [Abstract] [Full Text] [PDF] [Request Permissions]  

R. M. Silver
Endothelin and scleroderma lung disease
Rheumatology 2008 47: v25-v26; doi:10.1093/rheumatology/ken283 [Abstract] [Full Text] [PDF] [Request Permissions]  

K. W. Frommer and U. Müller-Ladner
Expression and function of ETA and ETB receptors in SSc
Rheumatology 2008 47: v27-v28; doi:10.1093/rheumatology/ken274 [Abstract] [Full Text] [PDF] [Request Permissions]  

Trial and Outcome Measures Back

D. E. Furst
Outcome measures in rheumatologic clinical trials and systemic sclerosis
Rheumatology 2008 47: v29-v30; doi:10.1093/rheumatology/ken269 [Abstract] [Full Text] [PDF] [Request Permissions]  

D. Khanna
A standardized core set for systemic sclerosis clinical trials. First step in development of combined response index
Rheumatology 2008 47: v31-v32; doi:10.1093/rheumatology/ken266 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Sánchez-Román, C. F. Opitz, O. Kowal-Bielecka, F. J. García-Hernández, M. J. Castillo-Palma, and D. Pittrow for the EPOSS-OMERACT Group
Screening for PAH in patients with systemic sclerosis: focus on Doppler echocardiography
Rheumatology 2008 47: v33-v35; doi:10.1093/rheumatology/ken306 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. P. Doran and D. J. Veale
Biomarkers in systemic sclerosis
Rheumatology 2008 47: v36-v38; doi:10.1093/rheumatology/ken270 [Abstract] [Full Text] [PDF] [Request Permissions]  

O. Kowal-Bielecka, M. Delcroix, A. Vonk-Noordegraaf, M. M. Hoeper, and R. Naeije
Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis
Rheumatology 2008 47: v39-v41; doi:10.1093/rheumatology/ken308 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. Vonk Noordegraaf and R. Naeije
Right ventricular function in scleroderma-related pulmonary hypertension
Rheumatology 2008 47: v42-v43; doi:10.1093/rheumatology/ken284 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. Czirják, I. Foeldvari, and U. Müller-Ladner
Skin involvement in systemic sclerosis
Rheumatology 2008 47: v44-v45; doi:10.1093/rheumatology/ken309 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Matucci-Cerinic and J. R. Seibold
Digital ulcers and outcomes assessment in scleroderma
Rheumatology 2008 47: v46-v47; doi:10.1093/rheumatology/ken310 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. U. Wells, J. Behr, and R. Silver
Outcome measures in the lung
Rheumatology 2008 47: v48-v50; doi:10.1093/rheumatology/ken311 [Abstract] [Full Text] [PDF] [Request Permissions]  

Y. Allanore, C. Meune, and A. Kahan
Outcome measures for heart involvement in systemic sclerosis
Rheumatology 2008 47: v51-v53; doi:10.1093/rheumatology/ken268 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. P. Denton
Renal manifestations of systemic sclerosis—clinical features and outcome assessment
Rheumatology 2008 47: v54-v56; doi:10.1093/rheumatology/ken307 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. R. Seibold, A. Tyndall, and D. E. Furst
Trial design: how must we move ahead?
Rheumatology 2008 47: v57-v58; doi:10.1093/rheumatology/ken312 [Abstract] [Full Text] [PDF] [Request Permissions]  

Interstitial Lung Disease - Beyond Cyclophosphamide Back

A. U. Wells
High-resolution computed tomography and scleroderma lung disease
Rheumatology 2008 47: v59-v61; doi:10.1093/rheumatology/ken271 [Abstract] [Full Text] [PDF] [Request Permissions]  

R. M. Silver and A. U. Wells
Histopathology and bronchoalveolar lavage
Rheumatology 2008 47: v62-v64; doi:10.1093/rheumatology/ken272 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Behr and D. E. Furst
Pulmonary function tests
Rheumatology 2008 47: v65-v67; doi:10.1093/rheumatology/ken313 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. J. Impens, S. Wangkaew, and J. R. Seibold
The 6-minute walk test in scleroderma—how measuring everything measures nothing
Rheumatology 2008 47: v68-v69; doi:10.1093/rheumatology/ken273 [Abstract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.